Julian Adams
Julian Adams · Science & Medicine
Medicinal chemist, co-developer of the cancer drug bortezomib (Velcade)
1954, Quebec City, Quebec, Canada
Canada · United States
Julian Adams is recognized among Jewish contributors to Science & Medicine — Medicinal chemist, co-developer of the cancer drug bortezomib (Velcade)
Julian Adams is a Canadian-American medicinal chemist who led the synthesis and development of the proteasome inhibitor bortezomib (Velcade), a first-in-class drug that transformed the treatment of multiple myeloma; he is also credited with the HIV drug nevirapine (Viramune). He earned degrees at McGill and a PhD at MIT and won the 2012 Warren Alpert Foundation Prize. He is Jewish.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Chemistry
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Medicinal chemist, co-developer of the cancer drug bortezomib (Velcade)
Source: Jinfo.org — Jews in Chemistry
Similar Contributors
Harry Yale
Barnett Rosenberg
